Contrast‐enhanced ultrasound (CEUS) of benign and malignant renal tumors: Distinguishing CEUS features differ with tumor size. (4th September 2022)
- Record Type:
- Journal Article
- Title:
- Contrast‐enhanced ultrasound (CEUS) of benign and malignant renal tumors: Distinguishing CEUS features differ with tumor size. (4th September 2022)
- Main Title:
- Contrast‐enhanced ultrasound (CEUS) of benign and malignant renal tumors: Distinguishing CEUS features differ with tumor size
- Authors:
- Zhu, Jianing
Li, Nan
Zhao, Ping
Wang, Yanjie
Song, Qing
Song, Luda
Li, Qiuyang
Luo, Yukun - Abstract:
- Abstract: Background: Contrast‐enhanced ultrasound (CEUS) is now a guideline‐recommended strategy for diagnosing renal lesions. Tumor size is related to the risk of the treatment and prognosis in renal tumors. Thus, we aim to analyze the CEUS features of solid renal tumors in relation to tumor size. Methods: The CEUS appearance of 156 pathologically diagnosed solid renal tumors were retrospectively analyzed. Three groups were stratified according to the tumor size (≤2 cm [group I], 2.1–4 cm [group II] and 4.1–7 cm [group III]). For each group, the features of wash‐in type, enhancement degree, enhancement homogeneity, and the presence of a pseudocapsule sign were compared between benign and malignant tumors. Results: All 156 included lesions were detected by CEUS. The proportion of benign tumors in three size groups was 37.1%, 19.4%, and 20.4%, respectively. The proportion of malignant tumors was highest (80.6%) in group II, followed by group III (79.6%) and group I (62.9%). In group I, malignant and benign tumors differed significantly in the presence of a pseudocapsule sign ( p = 0.015) and homogeneity ( p = 0.007). In group II, the degree of enhancement differed ( p = 0.02) between tumor types. In group III, the two tumor types differed in both the wash‐in pattern ( p = 0.015) and enhancement degree ( p = 0.024). The weighted and Cohen's kappa values for the concordance between inter‐observer agreement ranged from 0.31 (95% CI: 0.36–0.57) to 0.90 (95% CI: 0.77–1.00).Abstract: Background: Contrast‐enhanced ultrasound (CEUS) is now a guideline‐recommended strategy for diagnosing renal lesions. Tumor size is related to the risk of the treatment and prognosis in renal tumors. Thus, we aim to analyze the CEUS features of solid renal tumors in relation to tumor size. Methods: The CEUS appearance of 156 pathologically diagnosed solid renal tumors were retrospectively analyzed. Three groups were stratified according to the tumor size (≤2 cm [group I], 2.1–4 cm [group II] and 4.1–7 cm [group III]). For each group, the features of wash‐in type, enhancement degree, enhancement homogeneity, and the presence of a pseudocapsule sign were compared between benign and malignant tumors. Results: All 156 included lesions were detected by CEUS. The proportion of benign tumors in three size groups was 37.1%, 19.4%, and 20.4%, respectively. The proportion of malignant tumors was highest (80.6%) in group II, followed by group III (79.6%) and group I (62.9%). In group I, malignant and benign tumors differed significantly in the presence of a pseudocapsule sign ( p = 0.015) and homogeneity ( p = 0.007). In group II, the degree of enhancement differed ( p = 0.02) between tumor types. In group III, the two tumor types differed in both the wash‐in pattern ( p = 0.015) and enhancement degree ( p = 0.024). The weighted and Cohen's kappa values for the concordance between inter‐observer agreement ranged from 0.31 (95% CI: 0.36–0.57) to 0.90 (95% CI: 0.77–1.00). Conclusions: CEUS features of malignant and benign renal tumors change along with the tumor size. The use of CEUS features in the diagnosis of benign and malignant tumors requires consideration of tumor size. Abstract : This study shows that CEUS features of malignant and benign renal tumors change along with the tumor size. The use of CEUS features in the diagnosis of benign and malignant tumors requires consideration of tumor size. … (more)
- Is Part Of:
- Cancer medicine. Volume 12:Number 3(2023)
- Journal:
- Cancer medicine
- Issue:
- Volume 12:Number 3(2023)
- Issue Display:
- Volume 12, Issue 3 (2023)
- Year:
- 2023
- Volume:
- 12
- Issue:
- 3
- Issue Sort Value:
- 2023-0012-0003-0000
- Page Start:
- 2551
- Page End:
- 2559
- Publication Date:
- 2022-09-04
- Subjects:
- contrast‐enhanced ultrasound -- imaging examinations -- solid renal tumors -- tumor size
616.994005 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2045-7634 ↗ - DOI:
- 10.1002/cam4.5101 ↗
- Languages:
- English
- ISSNs:
- 2045-7634
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25977.xml